63.75

0.67% -0.43

Invesco Biotechnology & Genome ETF (PBE)

Overview News Price History Option Chain Discussions Forecast Dividend History

Invesco Biotechnology & Genome ETF stock is currently priced at $63.75, with a 24-hour trading volume of 6,145. It has seen a -0.67% decreased in the last 24 hours and a +1.40% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $63.95 pivot point. If it approaches the $63.67 support level, significant changes may occur.

Previous Close:

$64.18

Open:

$63.86

24h Volume:

6,145

Market Cap:

$281.93M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+1.42%

1M Performance:

+1.40%

6M Performance:

+15.26%

1Y Performance:

+2.43%

1D Range:

$63.64

$64.29

52W Range:

$52.47

$67.76

Invesco Biotechnology & Genome ETF Stock (PBE) Company Profile

Name

Invesco Biotechnology & Genome ETF

Sector

Financial (4528)

Industry

Exchange Traded Fund (3070)

Phone

800-983-0903

Address

Employee

Twitter

@InvescoUS

Next Earnings Date

Latest SEC Filings

PBE's Discussions on Twitter

Invesco Biotechnology & Genome ETF Stock (PBE) Latest News

Invesco Biotechnology & Genome ETF Stock (PBE) Financials Data

There is no financial data for Invesco Biotechnology & Genome ETF (PBE). Check out other stocks for more information.

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.